MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518 | -81.4% | 11,900 | -84.5% | 0.00% | -80.0% |
| Q2 2023 | $2,778 | -1.2% | 76,900 | +1.7% | 0.02% | -6.2% |
| Q1 2023 | $2,811 | -17.9% | 75,600 | 0.0% | 0.02% | -27.3% |
| Q4 2022 | $3,425 | -99.9% | 75,600 | -0.1% | 0.02% | -37.1% |
| Q3 2022 | $5,287,000 | -4.2% | 75,700 | -7.9% | 0.04% | -2.8% |
| Q2 2022 | $5,518,000 | +28.6% | 82,200 | +57.5% | 0.04% | +50.0% |
| Q1 2022 | $4,292,000 | -43.9% | 52,200 | 0.0% | 0.02% | -36.8% |
| Q4 2021 | $7,657,000 | -17.1% | 52,200 | 0.0% | 0.04% | -20.8% |
| Q3 2021 | $9,235,000 | +35.5% | 52,200 | +23.7% | 0.05% | +33.3% |
| Q2 2021 | $6,817,000 | -48.3% | 42,200 | -45.1% | 0.04% | -52.0% |
| Q1 2021 | $13,173,000 | -26.8% | 76,900 | -6.1% | 0.08% | -31.2% |
| Q4 2020 | $17,989,000 | +33.6% | 81,900 | +1.0% | 0.11% | +10.1% |
| Q3 2020 | $13,467,000 | +21.1% | 81,100 | -16.7% | 0.10% | +110.6% |
| Q2 2020 | $11,120,000 | +285.7% | 97,400 | +159.7% | 0.05% | -24.2% |
| Q1 2020 | $2,883,000 | -29.0% | 37,500 | +19.0% | 0.06% | -11.4% |
| Q4 2019 | $4,059,000 | -7.8% | 31,500 | -44.2% | 0.07% | -21.3% |
| Q3 2019 | $4,402,000 | +4.2% | 56,500 | +37.8% | 0.09% | +14.1% |
| Q2 2019 | $4,223,000 | +44.0% | 41,000 | +2.5% | 0.08% | +36.8% |
| Q1 2019 | $2,932,000 | – | 40,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |